NASDAQ: NEPH - Nephros, Inc.

Rentabilité sur six mois: +34.59%
Rendement en dividendes: 0%
Secteur: Healthcare

Calendrier des promotions Nephros, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Nephros, Inc.

Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.

plus de détails
The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

IPO date 2004-09-21
ISIN US6406714005
Industry Household Durables
Sector Consumer Discretionary
Валюта usd
Валюта отчета usd
Сайт https://www.nephros.com
Цена ао 2.17
Changement de prix par jour: 0% (2.14)
Changement de prix par semaine: +12.63% (1.9)
Changement de prix par mois: +13.23% (1.89)
Changement de prix sur 3 mois: +40.79% (1.52)
Changement de prix sur six mois: +34.59% (1.59)
Changement de prix par an: -9.32% (2.36)
Evolution du prix sur 3 ans: +4.39% (2.05)
Evolution du prix sur 5 ans: -75.26% (8.65)
Evolution des prix depuis le début de l'année: +43.62% (1.49)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 1.11 9
P/BV 1.83 8
P/E 212.04 1
EV/EBITDA 58.78 1
Total: 5.25

Efficacité

Nom Signification Grade
ROA, % 0.6415 1
ROE, % 0.8735 1
Total: 0.8333

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA 6.22 0
Total: 6

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 64.67 8
Rentabilité Ebitda, % -105.16 0
Rentabilité EPS, % -101.34 0
Total: 1.6
Plus de détails

Établissements Volume Partager, %
Wexford Capital LP 3682724 48
Bard Associates Inc. 187318 2.44
Vanguard Group Inc 171310 2.23
Geode Capital Management, LLC 71037 0.93
HighTower Advisors, LLC 56710 0.74
Blair (William) & Company, L.L.C. 36249 0.47
Morgan Stanley 33774 0.44
Elkhorn Partners Limited Partnership 31900 0.42
State Street Corporation 15698 0.2
Mesirow Financial Investment Management, Inc. 15383 0.2



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Robert Banks President, CEO & Director 474.04k 1975 (50 années)
Ms. Judy F. Krandel C.F.A. Chief Financial Officer 147.01k 1965 (60 années)
Brianne McGuire Director of Brand, Marketing & Business Development N/A
Vashone R. Thomas Vice President of Quality, Regulatory, & Human Resources N/A
Mr. Greg Lucas President of Aether Water Systems N/A
Ms. Judy Mazzini Controller N/A
Mr. Alfred Vargas Director of Operations N/A
Mr. Daron G. Evans M.B.A., M.S. Chief Executive Officer of Specialty Renal Products, Inc 300.18k 1974 (51 année)

Adresse: United States, South Orange. NJ, 380 Lackawanna Place - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.nephros.com